Contineum Therapeutics Inc. Class A Common Stock (CTNM) Financial Ratios & Valuation Metrics Analysis - P/E, ROE, Debt Ratios & Profitability - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Contineum Therapeutics In...

    NASDAQ: CTNM · Real-Time Price · USD
    11.55
    0.20 (1.76%)
    At close: Oct 06, 2025, 12:26 PM

    Contineum Therapeutics Class A Common Stock Ratios and Metrics

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    PE Ratio
    		 -6.71 17.13 -15.96 -13.34
    PEG Ratio
    		 0.02 -0.09 1.02 n/a
    PS Ratio
    		 n/a 7.79 n/a n/a
    PB Ratio
    		 1.43 -5.73 -4.15 -5.46
    P/FCF Ratio
    		 -8.5 20.56 -19.12 -14.64
    P/OCF Ratio
    		 -8.63 20.12 -19.23 -14.73
    OCF/S Ratio
    		 n/a 0.39 n/a n/a
    Debt / Equity Ratio
    		 0.03 -2.84 -1.48 -0.07
    Quick Ratio
    		 20.69 23.29 6.41 18.99
    Current Ratio
    		 20.69 23.29 6.41 18.99
    Asset Turnover
    		 n/a 0.38 n/a n/a
    Interest Coverage
    		 n/a -77.29 -58.56 -86.29
    Return on Equity
    		 -0.21 -0.33 0.26 0.41
    Return on Assets
    		 -0.2 0.17 -0.48 -0.41
    Return on Invested Capital
    		 -0.25 -0.13 -0.47 -0.42
    Dividend Yield
    		 n/a n/a n/a n/a
    Payout Ratio
    		 n/a n/a n/a n/a
    Gross Profit Margin
    		 n/a 1.00 n/a n/a
    Net Profit Margin
    		 n/a 0.45 n/a n/a
    Pretax Profit Margin
    		 n/a 0.46 n/a n/a
    Operating Profit Margin
    		 n/a -0.32 n/a n/a
    FCF Margin
    		 n/a 0.38 n/a n/a
    EBITDA Margin
    		 n/a 0.47 n/a n/a

    Add to Watchlist